Hi abdm, the following exerpt from Apr 11 update about FMCG (Sep10) is interesting...
"The broad range of products for which the OBJ technology is being evaluated has required the establishment of a number of new and innovative test models and the recruitment of leading specialists and industry experts familiar with these product categories. Various regulatory pre?]requisites in different parts of the world have introduced additional regulatory requirements which the Company is now addressing."
The "different parts of the world" regulatory issues, I think, are not the US, UK or EEC, given the current experience in the snr mgt team. So I reckon it is either China or India. Here's a read about big-pharma investment in China (albeit from a few years ago) which includes both GSK and Bristol-Myers Squibb.
http://seekingalpha.com/article/106790-big-pharma-steps-up-china-investment
bluebush
- Forums
- ASX - By Stock
- learn to play the game.
Hi abdm, the following exerpt from Apr 11 update about FMCG...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable